Dezerv

Fund Overview

Fund Size

Fund Size

₹13 Cr

Expense Ratio

Expense Ratio

0.22%

ISIN

ISIN

INF247L01BB1

Minimum SIP

Minimum SIP

-

Exit Load

Exit Load

-

Inception Date

Inception Date

29 Jul 2022

About this fund

Motilal Oswal S&P BSE Healthcare ETF is a Sector - Healthcare mutual fund schemes offered by Motilal Oswal Mutual Fund. This fund has been in existence for 1 years, 10 months and 20 days, having been launched on 29-Jul-22.
As of 14-Jun-24, it has a Net Asset Value (NAV) of ₹37.56, Assets Under Management (AUM) of 13.07 Crores, and an expense ratio of 0.22%.
  • Motilal Oswal S&P BSE Healthcare ETF has given a CAGR return of 30.13% since inception.
  • The fund's asset allocation comprises around 99.38% in equities, 0.00% in debts, and 0.62% in cash & cash equivalents.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+52.73%

+50.16% (Cat Avg.)

Since Inception

+30.13%

(Cat Avg.)

Portfolio Summaryas of 31st May 2024

Equity12.99 Cr99.38%
Others0.08 Cr0.62%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Sun Pharmaceuticals Industries LtdEquity2.25 Cr15.94%
Cipla LtdEquity1.12 Cr7.92%
Dr Reddy's Laboratories LtdEquity1.01 Cr7.13%
Apollo Hospitals Enterprise LtdEquity0.84 Cr5.94%
Max Healthcare Institute Ltd Ordinary SharesEquity0.79 Cr5.62%
Divi's Laboratories LtdEquity0.78 Cr5.55%
Lupin LtdEquity0.55 Cr3.88%
Aurobindo Pharma LtdEquity0.48 Cr3.38%
Zydus Lifesciences LtdEquity0.36 Cr2.56%
Fortis Healthcare LtdEquity0.35 Cr2.51%
Torrent Pharmaceuticals LtdEquity0.35 Cr2.49%
Glenmark Pharmaceuticals LtdEquity0.25 Cr1.76%
Alkem Laboratories LtdEquity0.24 Cr1.69%
Laurus Labs LtdEquity0.24 Cr1.67%
Ipca Laboratories LtdEquity0.23 Cr1.59%
Biocon LtdEquity0.2 Cr1.39%
Abbott India LtdEquity0.19 Cr1.38%
Gland Pharma LtdEquity0.18 Cr1.29%
J.B. Chemicals & Pharmaceuticals LtdEquity0.18 Cr1.27%
Syngene International LtdEquity0.17 Cr1.20%
GlaxoSmithKline Pharmaceuticals LtdEquity0.16 Cr1.12%
Global Health LtdEquity0.15 Cr1.07%
Ajanta Pharma LtdEquity0.14 Cr0.98%
Dr. Lal PathLabs LtdEquity0.14 Cr0.96%
Natco Pharma LtdEquity0.13 Cr0.90%
Krishna Institute of Medical Sciences LtdEquity0.13 Cr0.90%
Piramal Pharma LtdEquity0.13 Cr0.89%
Poly Medicure LtdEquity0.12 Cr0.82%
Narayana Hrudayalaya LtdEquity0.11 Cr0.81%
Sanofi India LtdEquity0.11 Cr0.81%
Pfizer LtdEquity0.1 Cr0.72%
Mankind Pharma LtdEquity0.1 Cr0.70%
Rainbow Childrens Medicare LtdEquity0.09 Cr0.67%
Aster DM Healthcare Ltd Ordinary SharesEquity0.09 Cr0.64%
Suven Pharmaceuticals LtdEquity0.09 Cr0.64%
Net Receivables / (Payables)Cash0.09 Cr0.62%
Granules India LtdEquity0.08 Cr0.57%
Strides Pharma Science LtdEquity0.08 Cr0.57%
Jubilant Pharmova LtdEquity0.08 Cr0.54%
Alembic Pharmaceuticals LtdEquity0.07 Cr0.53%
Neuland Laboratories LimitedEquity0.07 Cr0.50%
Metropolis Healthcare LtdEquity0.07 Cr0.49%
AstraZeneca Pharma India LtdEquity0.05 Cr0.39%
Procter & Gamble Health LtdEquity0.05 Cr0.38%
Marksans Pharma LtdEquity0.05 Cr0.38%
Vijaya Diagnostic Centre LtdEquity0.05 Cr0.38%
Eris Lifesciences Ltd Registered ShsEquity0.05 Cr0.36%
Wockhardt LtdEquity0.05 Cr0.33%
Caplin Point Laboratories LtdEquity0.04 Cr0.29%
Aarti Pharmalabs LtdEquity0.04 Cr0.28%
Concord Biotech LtdEquity0.03 Cr0.22%
FDC LtdEquity0.03 Cr0.21%
Kovai Medical Center & Hospital LtdEquity0.03 Cr0.21%
Unichem Laboratories LtdEquity0.03 Cr0.19%
Shilpa Medicare LtdEquity0.03 Cr0.19%
Ami Organics LtdEquity0.03 Cr0.18%
Glenmark Life Sciences LtdEquity0.02 Cr0.18%
Advanced Enzyme Technologies LtdEquity0.02 Cr0.17%
Aarti Drugs LtdEquity0.02 Cr0.15%
Sun Pharma Advanced Research Co LtdEquity0.02 Cr0.15%
HealthCare Global Enterprises LtdEquity0.02 Cr0.14%
Morepen Laboratories LtdEquity0.02 Cr0.13%
Sequent Scientific LtdEquity0.02 Cr0.12%
Indoco Remedies LtdEquity0.02 Cr0.11%
Hikal LtdEquity0.02 Cr0.11%
Dishman Carbogen Amics LtdEquity0.01 Cr0.10%
Jupiter Life Line Hospitals LtdEquity0.01 Cr0.10%
Krsnaa Diagnostics LtdEquity0.01 Cr0.10%
Indraprastha Medical Corp LtdEquity0.01 Cr0.10%
Supriya Lifescience LtdEquity0.01 Cr0.10%
Thyrocare Technologies LtdEquity0.01 Cr0.10%
IOL Chemicals And Pharmaceuticals LtdEquity0.01 Cr0.08%
Gufic Biosciences LtdEquity0.01 Cr0.08%
Novartis India LtdEquity0.01 Cr0.07%
Hester Biosciences LtdEquity0.01 Cr0.07%
Shalby LtdEquity0.01 Cr0.07%
Gujarat Themis Biosyn LtdEquity0.01 Cr0.07%
Yatharth Hospital and Trauma Care Services LtdEquity0.01 Cr0.07%
Blue Jet Healthcare LtdEquity0.01 Cr0.07%
Solara Active Pharma Sciences Ltd Ordinary SharesEquity0.01 Cr0.07%
RPG Life Sciences LtdEquity0.01 Cr0.06%
Tarsons Products LtdEquity0.01 Cr0.06%
Themis Medicare LtdEquity0.01 Cr0.06%
Syncom Formulation (India) LtdEquity0.01 Cr0.06%
Suven Life Sciences LtdEquity0.01 Cr0.06%
Bliss GVS Pharma LtdEquity0.01 Cr0.06%
Lincoln Pharmaceuticals LtdEquity0.01 Cr0.06%
Artemis Medicare Services Ltd Ordinary SharesEquity0.01 Cr0.05%
Kopran LtdEquity0.01 Cr0.05%
SMS Pharmaceuticals LtdEquity0.01 Cr0.05%
Sigachi Industries LtdEquity0.01 Cr0.05%
Innova Captab LtdEquity0.01 Cr0.05%
NGL Fine-Chem LtdEquity0.01 Cr0.04%
Vimta Labs LtdEquity0.01 Cr0.04%
KMC Speciality Hospitals (India) LtdEquity0 Cr0.03%
Medicamen Biotech LtdEquity0 Cr0.03%
Bajaj Healthcare LtdEquity0 Cr0.03%
Jagsonpal Pharmaceuticals LtdEquity0 Cr0.03%
Sastasundar Ventures LtdEquity0 Cr0.02%
Panacea Biotec LtdEquity0 Cr0.01%

Allocation By Market Cap (Equity)

Large Cap Stocks

45.66%

Mid Cap Stocks

31.15%

Small Cap Stocks

22.07%

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Healthcare13.9 Cr98.52%
Basic Materials0.05 Cr0.35%

Risk & Performance Ratios

Standard Deviation

This fund

--

Cat. avg.

14.65%

Lower the better

Sharpe Ratio

This fund

--

Cat. avg.

0.55

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

0.92

Higher the better

Fund Managers

SM

Swapnil Mayekar

Since July 2022

Rakesh Shetty

Rakesh Shetty

Since November 2022

Additional Scheme Detailsas of 31st May 2024

ISININF247L01BB1Expense Ratio0.22%Exit Load-Fund Size₹13 CrAge29 Jul 2022Lumpsum Minimum₹500Fund StatusOpen Ended Investment CompanyBenchmarkBSE Healthcare TR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Withdrawal within 1 year

Flat 15% tax on realised gains (STCG - short term capital gains)

Withdrawal after 1 year

10% tax on realised gains above Rs. 1 lakh per financial year (LTCG - long term capital gains)

Note: Mutual funds are subject to capital gains taxation with surcharge and cess, based on prevailing income tax rules and investor income. Taxation applies to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund nameExpense RatioExit LoadFund size
1Y
Motilal Oswal S&P BSE Healthcare ETF

Very High Risk

0.2%-₹13.07 Cr52.7%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Very High Risk

1.0%1.0%₹683.18 Cr55.4%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹683.18 Cr53.3%
Aditya Birla Sun Life Nifty Healthcare ETF

Very High Risk

0.2%-₹41.38 Cr50.7%
ITI Pharma and Healthcare Fund Direct Growth

Very High Risk

0.4%1.0%₹156.65 Cr45.7%
ITI Pharma and Healthcare Fund Regular Growth

Very High Risk

2.3%1.0%₹156.65 Cr42.9%
Mirae Asset Healthcare Fund Direct Growth

Very High Risk

0.5%1.0%₹2201.96 Cr52.2%
Mirae Asset Healthcare Fund Regular Growth

Very High Risk

2.0%1.0%₹2201.96 Cr50.0%
Nippon India Nifty Pharma ETF

Very High Risk

0.2%-₹552.77 Cr54.1%
Axis NIFTY Healthcare ETF

Very High Risk

0.3%-₹16.16 Cr49.5%

About the AMC

Total AUM

₹56,011 Cr

Address

Motilal Oswal Tower, Mumbai, 400 025

Other Funds by Motilal Oswal Mutual Fund

Fund nameExpense RatioExit LoadFund size
1Y
Motilal Oswal Small Cap Fund Direct Growth

Very High Risk

0.6%1.0%₹1748.48 Cr-
Motilal Oswal Developed Market Ex US ETFs Fund of Funds Direct Growth

Very High Risk

0.2%1.0%₹34.97 Cr-
Motilal Oswal Nifty Microcap 250 Index Fund Direct Growth

Very High Risk

0.4%1.0%₹1019.88 Cr-
Motilal Oswal Ultra Short Term Fund Direct Growth

Low to Moderate Risk

0.6%0.0%₹197.98 Cr6.7%
Motilal Oswal S&P BSE Low Volatility Index Fund Direct Growth

Very High Risk

0.4%1.0%₹52.27 Cr38.8%
Motilal Oswal Nifty Next 50 Index Fund Direct Growth

Very High Risk

0.3%1.0%₹277.10 Cr66.0%
Motilal Oswal Nifty 50 Index Fund Direct Growth

Very High Risk

0.2%0.0%₹478.24 Cr26.4%
Motilal Oswal Large and Midcap Fund Direct Growth

Very High Risk

0.5%1.0%₹4293.00 Cr56.1%
Motilal Oswal S&P 500 Index Fund Direct Growth

Very High Risk

0.6%1.0%₹3276.27 Cr27.1%
Motilal Oswal Focused Fund Direct Growth

Very High Risk

0.9%1.0%₹1848.27 Cr29.6%
Motilal Oswal Nasdaq 100 Fund of Fund Direct Growth

Very High Risk

0.2%1.0%₹4672.55 Cr33.6%
Motilal Oswal MSCI EAFE Top 100 Select Index Fund Direct Growth

Very High Risk

0.5%1.0%₹35.75 Cr12.4%
Motilal Oswal Midcap Fund Direct Growth

Very High Risk

0.6%1.0%₹10378.16 Cr62.7%
Motilal Oswal Nifty 200 Momentum 30 Index Fund Direct Growth

Very High Risk

0.3%1.0%₹600.89 Cr72.5%
Motilal Oswal Equity Hybrid Fund Direct Growth

Very High Risk

0.9%1.0%₹417.89 Cr18.4%
Motilal Oswal Asset Allocation Passive Fund of Fund - Aggressive Direct Growth

Very High Risk

0.1%1.0%₹65.57 Cr28.4%
Motilal Oswal Asset Allocation Passive Fund of Fund - Conservative Direct Growth

High Risk

0.0%1.0%₹41.39 Cr19.9%
Motilal Oswal Multi Asset Fund Direct Growth

High Risk

0.9%1.0%₹98.52 Cr17.1%
Motilal Oswal 5 Year G-Sec Fund of Fund Direct Growth

Moderate Risk

0.1%0.0%₹16.86 Cr6.6%
Motilal Oswal Nifty Smallcap 250 Index Fund Direct Growth

Very High Risk

0.4%1.0%₹687.59 Cr63.3%
Motilal Oswal Nifty Midcap 150 Index Fund Direct Growth

Very High Risk

0.3%1.0%₹1590.74 Cr58.9%
Motilal Oswal Nifty Bank Index Fund Direct Growth

Very High Risk

0.3%1.0%₹566.29 Cr14.1%
Motilal Oswal Nifty 500 Fund Direct Growth

Very High Risk

0.4%1.0%₹1130.15 Cr38.8%
Motilal Oswal Long Term Equity Fund Direct Growth

Very High Risk

0.7%0.0%₹3435.94 Cr59.6%
Motilal Oswal Flexicap Fund Direct Growth

Very High Risk

0.9%1.0%₹10034.64 Cr56.0%
Motilal Oswal S&P BSE Enhanced Value Index Fund Direct Growth

Very High Risk

0.4%1.0%₹609.71 Cr95.8%
Motilal Oswal S&P BSE Quality Index Fund Direct Growth

Very High Risk

0.4%1.0%₹16.60 Cr56.0%
Motilal Oswal Liquid Fund Direct Growth

Low to Moderate Risk

0.2%0.0%₹644.89 Cr7.0%
Motilal Oswal Gold and Silver ETFs Fund of Funds Direct Growth

Very High Risk

0.2%0.0%₹71.34 Cr19.9%
Motilal Oswal Balance Advantage Fund Direct Growth

Very High Risk

1.0%1.0%₹1233.45 Cr31.3%
Motilal Oswal S&P BSE Financials ex Bank 30 Index Fund Direct Growth

Very High Risk

0.3%1.0%₹12.57 Cr40.3%

Risk Level

Your principal amount will be at Very High Risk

Very High Risk
Wealth Monitor

Unlock Expert Insights!

Maximise Returns with our Wealth Monitor App. Try it now!

Still got questions?
We're here to help.

The NAV of Motilal Oswal S&P BSE Healthcare ETF, as of 14-Jun-2024, is ₹37.56.
The fund's allocation of assets is distributed as 99.38% in equities, 0.00% in bonds, and 0.62% in cash and cash equivalents.
The fund managers responsible for Motilal Oswal S&P BSE Healthcare ETF are:-
  1. Swapnil Mayekar
  2. Rakesh Shetty